At a glance
ClinicalIndex Comparison RecordN/ACompleted· 392 target
Drug / intervention
Meropenem +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MERONEM: Observational Study About Efficacy of Meropenem in Comparison of Meropenem and Glycopeptide in Treatment of Neutropenia Febrile in Allogenic Blood Stem Cell Transplantation Patients
In Brief
An observational study evaluating Meropenem, Vancomycin, and 1 other intervention for Allogenic Blood Stem Cell Transplantation and Febrile Neutropenia. Completed, enrolled 392 participants across 64 sites.
Detailed Summary
Observational study to compare the treatment in neutropenic patients after allogenic blood stem cell transplantation, with meropenem or meropenem plus glycopeptide.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2002
First PostedApr 2007
Study CompletionApr 2009
TodayJul 2026
First PostedApr 19, 2007
Enrollment StartNov 1, 2002
Study CompletionApr 1, 2009
TodayJul 2, 2026
Posted 19.2 years ago
Interventions
Meropenemdrug
antibiotic
Vancomycindrug
Antibiotic
Teicoplanindrug
Antibiotic